BRIACELL THERAPEUTICS CORP. Adjustments to Additional Paid in Capital, Other
BRIACELL THERAPEUTICS CORP. (BCTX) reported Adjustments to Additional Paid in Capital, Other of -$199.21 thousand for the 12-month period ending 2024-07-31, per its 10-K filed 2025-10-16.
Financial Statements › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2025-10-16
- BRIACELL THERAPEUTICS CORP. adjustments to additional paid in capital, other for the quarter ending 2024-07-31 was $0.00.
- BRIACELL THERAPEUTICS CORP. adjustments to additional paid in capital, other for the quarter ending 2024-04-30 was $0.00.
- BRIACELL THERAPEUTICS CORP. adjustments to additional paid in capital, other for the quarter ending 2024-01-31 was $0.00.
- BRIACELL THERAPEUTICS CORP. adjustments to additional paid in capital, other for the quarter ending 2023-10-31 was -$199.21K.
- BRIACELL THERAPEUTICS CORP. adjustments to additional paid in capital, other for fiscal 2024 was -$199.21K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2024-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-16 | $0.00 derived: sum of 2 quarters · filed 2025-10-16 | $0.00 derived: sum of 3 quarters · filed 2025-10-16 | -$199.21K 10-K · filed 2025-10-16 |
| 2024-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-16 | $0.00 derived: sum of 2 quarters · filed 2025-06-16 | -$199.21K 10-Q · filed 2025-06-16 | |
| 2024-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-12 | -$199.21K 10-Q · filed 2025-03-12 | ||
| 2023-10-31 | -$199.21K 10-Q · filed 2024-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |